insights_auto
Por que 2359 caiu 2,19%?
Saiba maischevron_right
2359:HKG
WuXi AppTec Ord Shs H
HK$ 196,20
arrow_downward
-2,19%(-4,40) 1D
16 de out., 16:08:14 GMT+8 · HKD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para 2359…
Abrir
HK$ 203,80
Alta
HK$ 209,00
Baixa
HK$ 185,00
Valor de mercado
544,52 bi
Volume médio
3,91 mi
Volume
10,16 mi
Dividendo
1,22%
Dividendo trimestral
HK$ 0,60
Data de ex-dividendo
4 de set. de 2026
Índice P/L
23,98
Alto — 52 sem
HK$ 219,20
Baixo — 52 sem
HK$ 96,70
LPA
HK$ 8,18
Nº de funcionários
36 mil
Abrir
HK$ 203,80
Alta
HK$ 209,00
Baixa
HK$ 185,00
Valor de mercado
544,52 bi
Volume médio
3,91 mi
Volume
10,16 mi
Dividendo
1,22%
Dividendo trimestral
HK$ 0,60
Data de ex-dividendo
4 de set. de 2026
Índice P/L
23,98
Alto — 52 sem
HK$ 219,20
Baixo — 52 sem
HK$ 96,70
LPA
HK$ 8,18
Nº de funcionários
36 mil
Notícias
De fontes da web e parceiros de notícias
ad-hoc-news.de
·
há 9 horas
WuXi AppTec earns EcoVadis gold: what it means for WuXi AppTec stock
Perfil
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer. Wikipedia
Sobre WuXi AppTec Ord Shs H
CEOSteve Yang | Ge Li
Funcionários35,6 mil
Data de fundação1 de dez. de 2000
Sede-
Setor-